Sinew Pharma Inc. (TPEX:6634)
Taiwan · Delayed Price · Currency is TWD 60.00
0.00 (0.00%)
Aug 19, 2026, 11:49 AM CST
Sinew Pharma Market Cap
Sinew Pharma has a market cap or net worth of 4.28 billion as of August 18, 2026. Its market cap has increased by 24.95% in one year.
Market Cap
4.28B
Enterprise Value
3.29B
Revenue
47.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
60.00
ChartMarket Cap Chart
Since June 29, 2017, Sinew Pharma's market cap has increased from 1.90B to 4.28B, an increase of 125.02%. That is a compound annual growth rate of 9.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 4.10B | 46.81% |
| Dec 31, 2025 | 2.79B | -17.68% |
| Dec 31, 2024 | 3.39B | -29.30% |
| Dec 29, 2023 | 4.80B | -34.51% |
| Dec 30, 2022 | 7.33B | 29.47% |
| Dec 30, 2021 | 5.66B | 19.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 5.18B |
| Steminent Biotherapeutics | 5.18B |
| Mycenax Biotech | 4.97B |
| Medigen Biotechnology | 4.87B |
| UnicoCell Biomed | 4.33B |
| Pharmosa Biopharm | 4.31B |
| BioGend Therapeutics | 3.40B |
| Formosa Pharmaceuticals | 3.39B |